Apollon Wealth Management’s Prothena Corp PRTA Stock Holding History

Apollon Wealth Management’s Portfolio PRTA Stock Details PRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-7	Closed	–	–	554
2020 Q2	$0	Buy	+7	New	+$78	﹤0.01%	753

Other funds holding PRTA

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Apollon Wealth Management's PRTA Position: Q3 2020 in Review

Apollon Wealth Management sold out of Prothena Corp (PRTA) in Q3 2020, closing a stake of 7 shares.

Apollon Wealth Management first reported a position in PRTA in Q2 2020 and held it in 1 quarter. The position peaked at $0 in Q2 2020. 140 funds tracked by Wall St. Rank hold PRTA as of Q3 2020.

Apollon Wealth Management reported no remaining Prothena Corp position as of Q3 2020 after selling out during the quarter.
Apollon Wealth Management sold 7 Prothena Corp shares in Q3 2020.
Apollon Wealth Management first reported a position in Prothena Corp in Q2 2020 and held it in 1 quarter.
Apollon Wealth Management's Prothena Corp position peaked at $0 in Q2 2020.
140 funds tracked by Wall St. Rank held Prothena Corp as of Q3 2020.

Based on Apollon Wealth Management's 13F filing for Q3 2020, filed 3 Nov 2020.